These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30930441)

  • 21. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
    Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
    J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
    Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release.
    Nagpal S; Braner S; Modh H; Tan AXX; Mast MP; Chichakly K; Albrecht V; Wacker MG
    Eur J Pharm Biopharm; 2020 Aug; 153():257-272. PubMed ID: 32589926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma.
    Thies RL; Cowens DW; Cullis PR; Bally MB; Mayer LD
    Anal Biochem; 1990 Jul; 188(1):65-71. PubMed ID: 2221370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct and simultaneous determination of intra-liposomal and external sulfate in liposomal doxorubicin formulations by capillary electrophoresis/inductively coupled plasma-tandem mass spectrometry (CE/ICP-MS/MS).
    Ansar SM; Mudalige T
    Int J Pharm; 2019 Apr; 561():283-288. PubMed ID: 30844422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photo-triggered destabilization of nanoscopic vehicles by dihydroindolizine for enhanced anticancer drug delivery in cervical carcinoma.
    Singh P; Choudhury S; Kulanthaivel S; Bagchi D; Banerjee I; Ahmed SA; Pal SK
    Colloids Surf B Biointerfaces; 2018 Feb; 162():202-211. PubMed ID: 29195229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy.
    Farzaneh H; Ebrahimi Nik M; Mashreghi M; Saberi Z; Jaafari MR; Teymouri M
    Int J Pharm; 2018 Nov; 551(1-2):300-308. PubMed ID: 30243944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery.
    Chen KJ; Liang HF; Chen HL; Wang Y; Cheng PY; Liu HL; Xia Y; Sung HW
    ACS Nano; 2013 Jan; 7(1):438-46. PubMed ID: 23240550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
    Mamidi RN; Weng S; Stellar S; Wang C; Yu N; Huang T; Tonelli AP; Kelley MF; Angiuoli A; Fung MC
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1173-84. PubMed ID: 20661737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage.
    Cern A; Marcus D; Tropsha A; Barenholz Y; Goldblum A
    J Control Release; 2017 Apr; 252():18-27. PubMed ID: 28215669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice.
    Kress J; Rohrbach DJ; Carter KA; Luo D; Poon C; Aygun-Sunar S; Shao S; Lele S; Lovell JF; Sunar U
    Sci Rep; 2017 Nov; 7(1):15578. PubMed ID: 29138489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes.
    Csuhai E; Kangarlou S; Xiang TX; Ponta A; Bummer P; Choi D; Anderson BD
    J Pharm Sci; 2015 Mar; 104(3):1087-98. PubMed ID: 25561354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil).
    Tsukioka Y; Matsumura Y; Hamaguchi T; Koike H; Moriyasu F; Kakizoe T
    Jpn J Cancer Res; 2002 Oct; 93(10):1145-53. PubMed ID: 12417045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes.
    Kinoshita R; Ishima Y; Ikeda M; Kragh-Hansen U; Fang J; Nakamura H; Chuang VT; Tanaka R; Maeda H; Kodama A; Watanabe H; Maeda H; Otagiri M; Maruyama T
    J Control Release; 2015 Nov; 217():1-9. PubMed ID: 26302904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
    Yamamoto E; Miyazaki S; Aoyama C; Kato M
    Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.